View Older Stories View More Recent Stories

Apr 1, 2026 07:15AM William Blair Shuffles Analyst Conviction List for April 2026
Apr 1, 2026 05:52AM William Blair on nCino Inc. (NCNO): 'AI May Disrupt Pockets of SaaS—but the Playbook Is Different in Banking'
Mar 31, 2026 03:28PM William Blair on Biogen (BIIB): 'we see potential to add $1.54 billion in sales' through APLS deal
Mar 31, 2026 03:19PM William Blair on Marvell (MRVL): Nvidia partnership, investment 'should help quell' questions of IP quality
Mar 31, 2026 03:16PM William Blair on Aehr Test Systems (AEHR): new order estimated at $10m, 'confirmatory of our thesis'
Mar 31, 2026 11:55AM William Blair Downgrades Apellis Pharmaceuticals (APLS) to Market Perform
Mar 31, 2026 06:16AM William Blair Starts MiniMed Group (MMED) at Outperform
Mar 30, 2026 05:42PM William Blair Upgrades 10X Genomics (TXG) to Outperform
Mar 30, 2026 01:01PM Form 497K WILLIAM BLAIR FUNDS
Mar 30, 2026 01:00PM Form 497 WILLIAM BLAIR FUNDS
Mar 30, 2026 10:19AM William Blair on Incyte (INCY): 'encouraged' by Ph3 data and deepened responses
Mar 30, 2026 09:50AM William Blair: 'we view BridgeBio as a core smidcap biotech holding'
Mar 27, 2026 04:45PM William Blair on Autolus Therapeutics plc (AUTL): LT blockbuster oppty despite YTD stock decline
Mar 27, 2026 03:30PM William Blair on Sterling Construction (STRL): shares outperforming on Meta El Paso data center news
Mar 27, 2026 09:49AM William Blair on ARS Pharmaceuticals Inc (SPRY): FDA label update 'viewed positively'
Mar 27, 2026 09:24AM William Blair on Kura Sushi USA Inc. (KRUS): 'expect a solid re-inflection into positive comps'
Mar 27, 2026 05:19AM William Blair Starts Nlight (LASR) at Outperform
Mar 26, 2026 05:57PM William Blair Reiterates Market Perform Rating on Enerpac Tool Group (EPAC) despite service biz weakness
Mar 26, 2026 04:06PM Wolfspeed completes $475.9 million refinancing with convertible notes
Mar 26, 2026 04:05PM Strategic Refinancing and New Equity Issuance Support Wolfspeed’s Long-term Growth Potential
Mar 26, 2026 03:10PM William Blair stays Outperform on AAR Corporation (AIR): sees 20% upside in next 12 months
Mar 26, 2026 11:07AM William Blair on Cintas (CTAS): expected to continue 'strong earnings growth'
Mar 26, 2026 10:56AM William Blair stays Outperform on Viking Therapeutic (VKTX) amid 'torrid pace' in advancing VK2735
Mar 26, 2026 10:54AM William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive'
Mar 26, 2026 10:35AM Secondary Market Hits Record $220 Billion in 2025
Mar 26, 2026 09:21AM William Blair Reiterates Outperform Rating on MillerKnoll (MLKN) amid post-earnings selloff
Mar 26, 2026 08:48AM William Blair stays Outperform on Cardiff Oncology (CRDF) despite adoption hurdles, dilution risks
Mar 26, 2026 08:08AM William Blair stays Outperform rated on Karman Holdings Inc (KRMN) after solid earnings, guidance raise
Mar 26, 2026 07:43AM Adobe downgraded at William Blair on intensifying competitive pressure
Mar 26, 2026 04:37AM William Blair Downgrades Adobe (ADBE) to Market Perform
Mar 25, 2026 05:45PM William Blair stays Outperform on Ionis Pharmaceuticals (IONS); pricing update 'positive'
Mar 25, 2026 05:40PM William Blair stays Market Perform on WillScot Holdings Corp (WSC) amid soft Feb. dodge starts
Mar 25, 2026 12:57PM William Blair stays Outperform on Beam Therapeutics Inc (BEAM) after "decisive validation' of BEAM-302 profile
Mar 25, 2026 11:55AM Generac stock tumbles as data center deal hopes disappoint
Mar 25, 2026 08:50AM William Blair on Arm Holdings (ARM): new CPU product to pressure margins, but increases earnings power
Mar 25, 2026 06:02AM William Blair Reiterates Outperform Rating on Circle Internet Group (CRCL)
Mar 24, 2026 03:52PM William Blair stays Outperform on Vertical Aerospace Ltd. (EVTL) despite $110 million funding gap
Mar 24, 2026 11:40AM William Blair on Watsco (WSO): selloff 'an overreaction' to HD's Mingledorff's acquisition
Mar 24, 2026 10:50AM William Blair on Neurogene (NGNE): dosing update further de-risks NGN-401 profile
Mar 23, 2026 04:44PM William Blair maintains Outperform rated on Cabaletta Bio Inc. (CABA) amid trial progress
Mar 23, 2026 01:10PM Defense firm AEVEX files for NYSE IPO
Mar 23, 2026 11:51AM William Blair on Pyxis Oncology Inc. (PYXS): 'encouraged' by enrollment pace of dose-expansion study
Mar 23, 2026 09:51AM William Blair on Tarsus Pharmaceuticals (TARS): 'benefits from the large and motivated patient population'
Mar 23, 2026 09:50AM William Blair on MaxCyte Inc. (MXCT): CFO appointment 'not all that needle-moving'
Mar 23, 2026 08:48AM William Blair on Insmed (INSM): 'data overall supports approval'
Mar 23, 2026 07:08AM William Blair Downgrades Avepoint Inc. (AVPT) to Market Perform
Mar 23, 2026 07:06AM William Blair Downgrades Dropbox (DBX) to Underperform
Mar 23, 2026 07:05AM William Blair Double Downgrades GitLab Inc (GTLB) to Underperform
Mar 23, 2026 06:28AM William Blair on GoDaddy Inc (GDDY): 'we are optimistic'
Mar 23, 2026 06:01AM William Blair Starts Eupraxia Pharmaceuticals (EPRX) at Outperform
View More Recent Stories View Older Stories